Blood sugar improves with first gastrointestinal microbiome modulator, NM504
In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance—the body's response to consuming carbohydrates— after four weeks ...
Jun 23, 2014
0
0